International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 6 | Views: 162 | Weekly Hits: ⮙3 | Monthly Hits: ⮙3

Research Paper | Ayurveda | India | Volume 12 Issue 5, May 2023

A Comparative Pharmaceutico Clinical Study of Kaisore Guggulu and Rasabhra Guggulu on Vatarakta

Dr. Shibabrata Behera | Dr. Kamadev Das | Dr. Arun Kumar Das

Abstract: Vatarakta is a disease explained in Ayurveda involving Vata Dosha imbalance affecting Rakta Dhatu - blood tissue. Vatarakta is correlated with Gout in modern medical science. Gout is the true crystal deposition disease characterized by pain & swelling of first Metatarso-phalengeal joint initially followed by other joints with an abnormal elevation of Urate level in the body either due to over production or under excretion or sometimes both. As regards treatment a satisfactory cure is still limited. In this contest course of action indicating various remedies have been prescribed in Ayurvedic classics. The main objective of the study was to assess the comparative efficacy of Rasabhra Guggulu & Kaisore Guggulu mentioned in Samhitas with special reference to Vatarakta. The Sample size of the study was 60 divided into 2 groups, Group-1 i.e- 30 nos of patients were treated with Kaisore Guggulu and Group-2 i.e- 30 nos of patients were treated with Rasabhra guggulu. The result were analysed before and after treatment using student 't' test and other suitable statistical formulas. In all the symptoms of Vatarakta the paired 't' test has denoted that the result of both the groups were highly significant(p<0.001), which implies that both the drugs are effective in the treatment of Vatarakta.

Keywords: Vatarakta, Gout, Kaisore Guggulu, Rasabhra guggulu

Edition: Volume 12 Issue 5, May 2023,

Pages: 1332 - 1341

How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link

Verification Code will appear in 2 Seconds ... Wait